chr11-55913801-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001001960.1(OR5W2):c.782G>A(p.Arg261Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001960.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR5W2 | NM_001001960.1 | c.782G>A | p.Arg261Gln | missense_variant | 1/1 | ENST00000344514.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR5W2 | ENST00000344514.1 | c.782G>A | p.Arg261Gln | missense_variant | 1/1 | NM_001001960.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151988Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251172Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135780
GnomAD4 exome AF: 0.000156 AC: 228AN: 1461842Hom.: 0 Cov.: 32 AF XY: 0.000173 AC XY: 126AN XY: 727228
GnomAD4 genome AF: 0.000151 AC: 23AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.782G>A (p.R261Q) alteration is located in exon 1 (coding exon 1) of the OR5W2 gene. This alteration results from a G to A substitution at nucleotide position 782, causing the arginine (R) at amino acid position 261 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at